VistaGen Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
0.23
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.07
|
-0.08
|
-0.01
|
-14.29%
|
|
2022-06-30
|
-0.07
|
-0.10
|
-0.03
|
-42.86%
|
|
2022-03-31
|
-0.06
|
-0.09
|
-0.03
|
-50.00%
|
|
2021-12-31
|
-0.07
|
-0.05
|
0.02
|
28.57%
|
|
2021-09-30
|
-0.06
|
-0.07
|
-0.01
|
-16.67%
|
|
2021-06-30
|
-0.05
|
-0.04
|
0.01
|
20.00%
|
|
2021-03-31
|
-0.05
|
-0.20
|
-0.15
|
-300.00%
|
|
2020-12-31
|
-0.05
|
-0.07
|
-0.02
|
-40.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.18
|
|
2022-03-31
|
-0.25
|
|
2021-03-31
|
-0.39
|
|
2020-03-31
|
-0.50
|
|
2019-03-31
|
-0.91
|
|
2018-03-31
|
-1.13
|
|
2017-03-31
|
-1.58
|
|
2016-03-31
|
-30.89
|
|
2015-03-31
|
-12.17
|
|
2014-03-31
|
-3.80
|
|
2013-03-31
|
-21.84
|
|
2012-03-31
|
-17.18
|